The ethnic differences in the incidence, pathophysiology and management of
hypertensive disease, are particularly pertinent to the Black or Afro-Carib
bean populations, who have a high prevalence of hypertension and associated
complications, such as strokes and renal impairment. Our understanding of
the underlying pathophysiology of hypertensive disease and the optimal trea
tment of hypertension in Black patients continues to evolve, especially wit
h the introduction of new drugs and the need for prognostic data in this et
hnic population. We review the management of hypertensive disease in the bl
ack population, emphasizing race-related differences in the pathophysiology
of hypertension and the importance of tailored management in this group of
patients, including sensible application of nonpharmacological measures wi
th effective antihypertensive agents. For example, diuretics and calcium an
tagonists are suitable first-line agents in black hypertensives, whilst bet
a-blockers and the ACE inhibitors tend to be less effective at lowering blo
od pressure, due to the low renin state in these patients.